Command Palette

Search for a command to run...

Clinical Trials · NCT00845559

The Effects of Exenatide on Post-Meal Sugar Peaks and Vascular Health in Obese/Pre-Diabetic Young Adults

WithdrawnPhase 4Exenatide (Prohibited)
Phase
Phase 4
Recruitment status
Withdrawn
Sponsor
Yale University
Enrollment
0
Start date
Aug 2008
Locations
See registry
Primary endpoint
Whether treatment with exenatide attenuates post-prandial glycemic excursions as assessed by oral glucose tolerance testing (OGTT) and continuous monitoring system (CGMS) technology.
View Exenatide compound reference